Moderna Competitors and Similar CompaniesClear all

Moderna's competitors and similar companies include Regulus Therapeutics and Sarepta Therapeutics.
Moderna
Moderna
Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine.
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.
Sarepta Therapeutics
Sarepta Therapeutics
Sarepta Therapeutics is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapeutics, gene therapy and, other genetic therapeutic modalities for the treatment of rare diseases.
Founding Date
Founding Date
2010
Founding Date
2007
Founding Date
1980
Type
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Melbourne, AU
Paris, FR
München, DE
Tokyo, JP
Seoul, KR
Warszawa, PL
see more
Locations
San Diego, US HQ
Locations
Cambridge, US HQ
Dublin, IE
Zug, CH
Providence, US
Employees
Employees
5,60044% increase
Employees
2462% decrease
Employees
1,31413% increase
Valuation ($)
Valuation ($)
62.6 b
Valuation ($)
158.4 m
Valuation ($)
12.2 b
Twitter followers
Twitter followers
151.2 k
Twitter followers
790
Twitter followers
5 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
17
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
13
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
39.6
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
40.6
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
69.23%

Financial

Revenue (est.)
Revenue (est.)
$6.8b (FY, 2023)
Revenue (est.)
N/A
Revenue (est.)
$1.2b (FY, 2023)
Cost of goods
Cost of goods
$4.7b (FY, 2023)
Cost of goods
N/A
Cost of goods
$150.3m (FY, 2023)
Gross profit
Gross profit
$2.2b (FY, 2023)
Gross profit
N/A
Gross profit
$1.1b (FY, 2023)
Net income
Net income
($4.7b) (FY, 2023)
Net income
($30m) (FY, 2023)
Net income
($536m) (FY, 2023)

Operating

Patents Issued
Patents Issued
270 (FY, 2020)
Patents Issued
300 (FY, 2016)
Patents Issued
N/A

Funding

Total funding raised
Total funding raised
$ 1.8b
Total funding raised
$ 10m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Regulus Therapeutics
HQ
San Diego, US
Employees
24

Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.

View company
Sarepta Therapeutics
HQ
Cambridge, US
Employees
1,314↑ 13% increase

Sarepta Therapeutics is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapeutics, gene therapy and, other genetic therapeutic modalities for the treatment of rare diseases.

View company